A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 9/127 (2006.01) A61K 31/565 (2006.01) A61K 31/704 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2437768
Methods for treating proliferative diseases, especially breast cancers, comprising administering (1) a therapeutically effective amount of a liposomal anthracycline composition in association with (2) a therapeutically effective amount of an antibody directed against the extracellular domain of a growth factor receptor and optionally in association with (3) a therapeutically effective amount of an additional antineoplastic agent, are disclosed.
L'invention concerne des méthodes permettant de traiter des maladies prolifératives, notamment les cancers du sein, qui consiste à administrer 1) une quantité thérapeutiquement efficace d'une composition d'anthracycline liposomale associée à 2) une quantité thérapeutiquement efficace d'un anticorps dirigé contre le domaine extracellulaire d'un récepteur de facteur de croissance, et éventuellement à 3) une quantité thérapeutiquement efficace d'un agent antinéoplasique supplémentaire.
Emanuel David J.
Tendler Craig L.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Targetted anti-tumor drug delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targetted anti-tumor drug delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targetted anti-tumor drug delivery systems will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1411960